Acoustic neuroma overview: Difference between revisions
No edit summary |
|||
| Line 2: | Line 2: | ||
{{Acoustic neuroma}} | {{Acoustic neuroma}} | ||
{{CMG}}{{AE}}{{M.B}} {{Simrat}} | {{CMG}}{{AE}}{{M.B}} {{Simrat}} | ||
==Overview== | ==Overview<ref name="pmid338268212">{{cite journal| author=Carlson ML, Link MJ| title=Vestibular Schwannomas. | journal=N Engl J Med | year= 2021 | volume= 384 | issue= 14 | pages= 1335-1348 | pmid=33826821 | doi=10.1056/NEJMra2020394 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33826821 }}</ref>== | ||
The most common neoplasm of the cerebellopontine angle in adults is vestibular schwannoma (8% of all intracranial tumors). The term “vestibular schwannoma” is preferred over acoustic neuroma which is a misnomer. | |||
==Historical Perspective== | ==Historical Perspective== | ||
| Line 26: | Line 27: | ||
==Pathophysiology== | ==Pathophysiology== | ||
Acoustic neuroma arises from [[Schwann cells]], which are the [[Cell (biology)|cells]] involved in the conduction of [[Nervous system|nervous]] impulses along [[axons]], [[nerve]] development and [[Nerve regeneration|regeneration]]. On [[microscopic]] [[histopathological]] analysis, acoustic neuroma may display two types of growth patterns: Antoni type A and Antoni type B. Antoni type A growth pattern is composed of elongated [[Cell (biology)|cells]] with [[Cytoplasm|cytoplasmic]] processes arranged in [[Fascicle|fascicles]], little [[stromal]] [[matrix]] and verocay bodies. Antoni type B growth pattern is composed of loose meshwork of [[Cell (biology)|cells]], less dense [[Cell (biology)|cellular]] [[matrix]], microcysts and myxoid change. | Acoustic neuroma arises from [[Schwann cells]] of the vestibulocochlear (eighth cranial) nerve, which are the [[Cell (biology)|cells]] involved in the conduction of [[Nervous system|nervous]] impulses along [[axons]], [[nerve]] development and [[Nerve regeneration|regeneration]]. On [[microscopic]] [[histopathological]] analysis, acoustic neuroma may display two types of growth patterns: Antoni type A and Antoni type B. Antoni type A growth pattern is composed of elongated [[Cell (biology)|cells]] with [[Cytoplasm|cytoplasmic]] processes arranged in [[Fascicle|fascicles]], little [[stromal]] [[matrix]] and verocay bodies. Antoni type B growth pattern is composed of loose meshwork of [[Cell (biology)|cells]], less dense [[Cell (biology)|cellular]] [[matrix]], microcysts and myxoid change. the mean tumor size decreased from 2.8 cm to 0.7 cm | ||
==Causes== | ==Causes== | ||
Numerous studies show the correlation between [[Neurofibromatosis type II|Neurofibromatosis type 2 (NF2)]] and acoustic neuroma. Other causes can include exposure to occupational noise and cellular telephone use. | Numerous studies show the correlation between [[Neurofibromatosis type II|Neurofibromatosis type 2 (NF2)]] and acoustic neuroma. Other causes can include exposure to occupational noise and cellular telephone use. | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
Acoustic neuroma must be differentiated from [[meningioma]], intracranial epidermoid cyst, [[facial nerve]] [[schwannoma]], [[trigeminal]] [[schwannoma]], [[ependymoma]], leiomyoma, intranodal palisaded myofibroblastoma, [[malignant]] peripheral nerve sheath | Acoustic neuroma must be differentiated from [[meningioma]], intracranial epidermoid cyst, [[facial nerve]] [[schwannoma]], [[trigeminal]] [[schwannoma]], [[ependymoma]], leiomyoma, intranodal palisaded myofibroblastoma, [[malignant]] peripheral nerve sheath tumor (MPNST), [[gastrointestinal]] stromal tumor, [[neurofibroma]], [[Meniere's]] disease, and [[Bell's palsy]]. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
The [[incidence]] of acoustic neuroma ranges from 0.3 to 1 per 100, 000 individuals. | Enhanced diagnostics leading to increase detection has lead to rise in incidence of vestibular schwannoma. From the 1900s the incidence of vestibular schwannomas remained static, since patients presented with large tumors causing symptoms that had grown over a period of years without being detected. 1 case per 100,000 person-years in 1970, current incidence rates range from 3 to 5 cases per 100,000 person-years. 20 cases per 100,000 person-years in patient aged 70 years. The [[incidence]] of acoustic neuroma ranges from 0.3 to 1 per 100, 000 individuals. A lifetime prevalence is exceeding 1 case among 500 persons. Sporadic unilateral vestibular schwannomas, which account for more than 95% of cases. Women are more commonly affected by acoustic neuroma than men. Most cases of acoustic neuroma develop in individuals between 30 and 60 years of age. | ||
==Risk Factors== | ==Risk Factors== | ||
Common [[Risk factor|risk factors]] in the development of acoustic neuroma are [[neurofibromatosis type 2]] and [[radiation]] exposure. Less common [[Risk factor|risk factors]] include sporadic defects in [[Tumor suppressor gene|tumor suppressor genes]], exposure to loud noise, history of [[parathyroid adenoma]], and the use of cellular phones. | Common [[Risk factor|risk factors]] in the development of acoustic neuroma are [[neurofibromatosis type 2]] and [[radiation]] exposure. Less common [[Risk factor|risk factors]] include sporadic defects in [[Tumor suppressor gene|tumor suppressor genes]], exposure to loud noise, history of [[parathyroid adenoma]], and the use of cellular phones. Several groups have suggested that environmental exposures, such as cell phone use or long-term noise exposure may increase the risk of tumorigenesis but this relation is still under study. Ionizing radiation are big risk factor | ||
==Screening== | ==Screening== | ||
According to the U.S. Preventive Services Task Force (USPTF), [[Screening (medicine)|screening]] for [[acoustic neuroma]] is not recommended. Evaluation for [[Neurofibromatosis type II|NF-2]] should be done in individuals with an apparently sporadic [[Acoustic neuroma|vestibular schwannoma]] occurring before the age of 30, or a [[spinal tumor]] or [[meningioma]] occurring at less than 20 years of age. | According to the U.S. Preventive Services Task Force (USPTF), [[Screening (medicine)|screening]] for [[acoustic neuroma]] is not recommended. Evaluation for [[Neurofibromatosis type II|NF-2]] should be done in individuals with an apparently sporadic [[Acoustic neuroma|vestibular schwannoma]] occurring before the age of 30, or a [[spinal tumor]] or [[meningioma]] occurring at less than 20 years of age. | ||
==Natural History, Complications and Prognosis== | ==Natural History, Complications and Prognosis== | ||
Approximately 50% of all acoustic neuromas grow slowly (1 - 2 mm/year). The growth rate is more rapid (greater than 2 mm/year) in about 20% of the [[Patient|patients]]. The [[tumor]] does not [[Metastasis|metastasize]] to other parts of the [[Human body|body]]. [[Hearing impairment|Hearing loss]], when occurs, is irreversible. If left untreated, an acoustic neuroma can block the flow of [[cerebrospinal fluid]] and cause [[hydrocephalus]], which may lead to severe [[Visual system|vision]] problems and difficulty [[breathing]] and [[swallowing]]. [[Complication (medicine)|Complications]] of acoustic neuroma include [[Hearing impairment|hearing loss]], [[Hydrocephalus]], and recurrence of the [[tumor]]. Small, slow-growing [[Tumor|tumors]] may not need treatment. [[Patient|Patients]] experience similar [[quality of life]] whether treatment is [[observation]], [[radiation]], or [[surgery]]. | Approximately 50% of all acoustic neuromas grow slowly (1 - 2 mm/year). The growth rate is more rapid (greater than 2 mm/year) in about 20% of the [[Patient|patients]]. The [[tumor]] does not [[Metastasis|metastasize]] to other parts of the [[Human body|body]]. [[Hearing impairment|Hearing loss]], when occurs, is irreversible. If left untreated, an acoustic neuroma can block the flow of [[cerebrospinal fluid]] and cause [[hydrocephalus]], which may lead to severe [[Visual system|vision]] problems and difficulty [[breathing]] and [[swallowing]]. [[Complication (medicine)|Complications]] of acoustic neuroma include [[Hearing impairment|hearing loss]], [[Hydrocephalus]], and recurrence of the [[tumor]]. Small, slow-growing [[Tumor|tumors]] may not need treatment. [[Patient|Patients]] experience similar [[quality of life]] whether treatment is [[observation]], [[radiation]], or [[surgery]]. | ||
An important ramification of increased disease detection is a potential for overtreatment, which could result in unnecessary complications and health care expenditures. Many patients, who just decades ago would have lived out their lives without having their tumors detected, are now receiving treatment | |||
==Diagnostic Study of Choice== | ==Diagnostic Study of Choice== | ||
[[Gadolinium]]-enhanced [[Magnetic resonance imaging|MRI scan]] is the definitive [[diagnostic test]] for acoustic neuroma and can identify [[tumors]] as small as 1-2 millimeter in [[diameter]]. On [[brain]] [[Magnetic resonance imaging|MRI]], acoustic neuroma characterized by hypointense mass on T1-weighted [[Magnetic resonance imaging|MRI]], and hyperintense mass on T2-weighted [[Magnetic resonance imaging|MRI]]. | Widespread access to sensitive neuro-diagnostic imaging has led to a remarkable rise in the detection of vestibular schwannomas. [[Gadolinium]]-enhanced [[Magnetic resonance imaging|MRI scan]] is the definitive [[diagnostic test]] for acoustic neuroma and can identify [[tumors]] as small as 1-2 millimeter in [[diameter]]. On [[brain]] [[Magnetic resonance imaging|MRI]], acoustic neuroma characterized by hypointense mass on T1-weighted [[Magnetic resonance imaging|MRI]], and hyperintense mass on T2-weighted [[Magnetic resonance imaging|MRI]]. | ||
==History and Symptoms== | ==History and Symptoms== | ||
| Line 57: | Line 60: | ||
[[CT scan]] of the [[head]] may be [[Diagnosis|diagnostic]] of acoustic neuroma. Findings on [[Computed tomography|CT scan]] diagnostic of acoustic neuroma include erosion and widening of the [[Internal auditory meatus|internal acoustic canal]]. | [[CT scan]] of the [[head]] may be [[Diagnosis|diagnostic]] of acoustic neuroma. Findings on [[Computed tomography|CT scan]] diagnostic of acoustic neuroma include erosion and widening of the [[Internal auditory meatus|internal acoustic canal]]. | ||
==MRI== | ==MRI== | ||
[[Gadolinium]]-enhanced [[Magnetic resonance imaging|MRI scan]] is the definitive [[diagnostic test]] for acoustic neuroma and can identify [[tumors]] as small as 1-2 millimeter in [[diameter]]. On [[brain]] [[Magnetic resonance imaging|MRI]], acoustic neuroma characterized by hypointense mass on T1-weighted [[Magnetic resonance imaging|MRI]], and hyperintense mass on T2-weighted [[Magnetic resonance imaging|MRI]]. | 25% of all new cases are diagnosed incidentally during imaging that was obtained for unrelated indications (e.g., headache)[[Gadolinium|. Gadolinium]]-enhanced [[Magnetic resonance imaging|MRI scan]] is the definitive [[diagnostic test]] for acoustic neuroma and can identify [[tumors]] as small as 1-2 millimeter in [[diameter]]. On [[brain]] [[Magnetic resonance imaging|MRI]], acoustic neuroma characterized by hypointense mass on T1-weighted [[Magnetic resonance imaging|MRI]], and hyperintense mass on T2-weighted [[Magnetic resonance imaging|MRI]]. | ||
==Other Imaging Findings== | ==Other Imaging Findings== | ||
There are no other [[imaging]] findings associated with acoustic neuroma. | There are no other [[imaging]] findings associated with acoustic neuroma. | ||
| Line 73: | Line 76: | ||
[[Prevention (medical)|Secondary prevention]] strategies following acoustic neuroma treatment include follow-up [[Magnetic resonance imaging|MRI scans]]. | [[Prevention (medical)|Secondary prevention]] strategies following acoustic neuroma treatment include follow-up [[Magnetic resonance imaging|MRI scans]]. | ||
==References== | ==References== | ||
Revision as of 17:59, 3 May 2021
|
Acoustic neuroma Microchapters | |
|
Diagnosis | |
|---|---|
|
Treatment | |
|
Case Studies | |
|
Acoustic neuroma overview On the Web | |
|
American Roentgen Ray Society Images of Acoustic neuroma overview | |
|
Risk calculators and risk factors for Acoustic neuroma overview | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohsen Basiri M.D. Simrat Sarai, M.D. [2]
Overview[1]
The most common neoplasm of the cerebellopontine angle in adults is vestibular schwannoma (8% of all intracranial tumors). The term “vestibular schwannoma” is preferred over acoustic neuroma which is a misnomer.
Historical Perspective
Acoustic neuroma was first described by Eduard Sandifort in 1777.
Bilateral acoustic neuroma was first described by Wishart in 1822.
Sir Charles Bell provided the first known report of a case of Meckel cave neuroma in 1833, demonstrating the relationship of the tumor to the cerebellopontine angle.
Sir Charles Ballance successfully removed an acoustic neuroma in 1894.
Since then, tremendous efforts of many surgeons have been continuing to provide surgical approaches to improve outcomes of treatments and decrease side effects of interventions.
Classification
Acoustic neuroma may be classified according to the findings on
- microscopic histopathology, Based on microscopic histopathology, acoustic neuroma may be classified into four subtypes: conventional schwannoma, cellular schwannoma, plexiform schwannoma, and melanotic schwannoma. While acoustic neuromas are benign tumors, there is no established system for the staging of acoustic neuromas.
- Associated with neurofibromatosis type 2 or not.
- Koos grading scale provides four grades based on extra meatal extension and compression of the brain stem , a reliable method for tumor classification which is used in practice.
Pathophysiology
Acoustic neuroma arises from Schwann cells of the vestibulocochlear (eighth cranial) nerve, which are the cells involved in the conduction of nervous impulses along axons, nerve development and regeneration. On microscopic histopathological analysis, acoustic neuroma may display two types of growth patterns: Antoni type A and Antoni type B. Antoni type A growth pattern is composed of elongated cells with cytoplasmic processes arranged in fascicles, little stromal matrix and verocay bodies. Antoni type B growth pattern is composed of loose meshwork of cells, less dense cellular matrix, microcysts and myxoid change. the mean tumor size decreased from 2.8 cm to 0.7 cm
Causes
Numerous studies show the correlation between Neurofibromatosis type 2 (NF2) and acoustic neuroma. Other causes can include exposure to occupational noise and cellular telephone use.
Differential Diagnosis
Acoustic neuroma must be differentiated from meningioma, intracranial epidermoid cyst, facial nerve schwannoma, trigeminal schwannoma, ependymoma, leiomyoma, intranodal palisaded myofibroblastoma, malignant peripheral nerve sheath tumor (MPNST), gastrointestinal stromal tumor, neurofibroma, Meniere's disease, and Bell's palsy.
Epidemiology and Demographics
Enhanced diagnostics leading to increase detection has lead to rise in incidence of vestibular schwannoma. From the 1900s the incidence of vestibular schwannomas remained static, since patients presented with large tumors causing symptoms that had grown over a period of years without being detected. 1 case per 100,000 person-years in 1970, current incidence rates range from 3 to 5 cases per 100,000 person-years. 20 cases per 100,000 person-years in patient aged 70 years. The incidence of acoustic neuroma ranges from 0.3 to 1 per 100, 000 individuals. A lifetime prevalence is exceeding 1 case among 500 persons. Sporadic unilateral vestibular schwannomas, which account for more than 95% of cases. Women are more commonly affected by acoustic neuroma than men. Most cases of acoustic neuroma develop in individuals between 30 and 60 years of age.
Risk Factors
Common risk factors in the development of acoustic neuroma are neurofibromatosis type 2 and radiation exposure. Less common risk factors include sporadic defects in tumor suppressor genes, exposure to loud noise, history of parathyroid adenoma, and the use of cellular phones. Several groups have suggested that environmental exposures, such as cell phone use or long-term noise exposure may increase the risk of tumorigenesis but this relation is still under study. Ionizing radiation are big risk factor
Screening
According to the U.S. Preventive Services Task Force (USPTF), screening for acoustic neuroma is not recommended. Evaluation for NF-2 should be done in individuals with an apparently sporadic vestibular schwannoma occurring before the age of 30, or a spinal tumor or meningioma occurring at less than 20 years of age.
Natural History, Complications and Prognosis
Approximately 50% of all acoustic neuromas grow slowly (1 - 2 mm/year). The growth rate is more rapid (greater than 2 mm/year) in about 20% of the patients. The tumor does not metastasize to other parts of the body. Hearing loss, when occurs, is irreversible. If left untreated, an acoustic neuroma can block the flow of cerebrospinal fluid and cause hydrocephalus, which may lead to severe vision problems and difficulty breathing and swallowing. Complications of acoustic neuroma include hearing loss, Hydrocephalus, and recurrence of the tumor. Small, slow-growing tumors may not need treatment. Patients experience similar quality of life whether treatment is observation, radiation, or surgery.
An important ramification of increased disease detection is a potential for overtreatment, which could result in unnecessary complications and health care expenditures. Many patients, who just decades ago would have lived out their lives without having their tumors detected, are now receiving treatment
Diagnostic Study of Choice
Widespread access to sensitive neuro-diagnostic imaging has led to a remarkable rise in the detection of vestibular schwannomas. Gadolinium-enhanced MRI scan is the definitive diagnostic test for acoustic neuroma and can identify tumors as small as 1-2 millimeter in diameter. On brain MRI, acoustic neuroma characterized by hypointense mass on T1-weighted MRI, and hyperintense mass on T2-weighted MRI.
History and Symptoms
Chronic gradual unilateral hearing impairment is the most common complaint present in 95% of the patients. Common symptoms include chronic gradual unilateral hearing loss, ringing in the ear, Disequilibrium, facial numbness, facial pain, and Headache. Less common symptoms include facial muscle weakness, taste disturbances, dryness of the eyes, sudden lacrimation, speech problem, difficulty swallowing, aspiration, hoarseness, and ear pain.
Physical Examination
Patients with acoustic neuroma usually appear normal. Physical examination of patients with acoustic neuroma is usually remarkable for Sensorineural hearing loss in the affected ear, positive Rinne test, abnormal Weber test, Papilledema, Nystagmus, Diplopia on lateral gaze, decreased or absent ipsilateral corneal reflex, facial twitching or hypesthesia, Drooling, drooping on one side of the face, loss of taste, and ataxia.
Laboratory Findings
There are no diagnostic laboratory findings associated with acoustic neuroma.
Electrocardiogram
There are no electrocardiogram findings associated with acoustic neuroma.
X Ray
There are no x-ray findings associated with acoustic neuroma.
Echocardiography/Ultrasound
There are no echocardiography or ultrasound findings associated with acoustic neuroma.
CT
CT scan of the head may be diagnostic of acoustic neuroma. Findings on CT scan diagnostic of acoustic neuroma include erosion and widening of the internal acoustic canal.
MRI
25% of all new cases are diagnosed incidentally during imaging that was obtained for unrelated indications (e.g., headache). Gadolinium-enhanced MRI scan is the definitive diagnostic test for acoustic neuroma and can identify tumors as small as 1-2 millimeter in diameter. On brain MRI, acoustic neuroma characterized by hypointense mass on T1-weighted MRI, and hyperintense mass on T2-weighted MRI.
Other Imaging Findings
There are no other imaging findings associated with acoustic neuroma.
Other Diagnostic Studies
Audiometry as the best initial screening test for the diagnosis of acoustic neuroma. It can detect asymmetric sensorineural hearing impairment in about 95% of the patients. Brain stem-evoked response audiometry (ABR, BAER, or BSER) may be done in some cases with unexplained asymmetries in standard audiometric testing as a further screening measure and an abnormal auditory brain stem response test should be followed by an MRI.
Medical Therapy
The mainstay of therapy for acoustic neuroma is surgery and radiation therapy. Since acoustic neuroma tends to be slow-growing and is a benign tumor, careful observation with follow-up MRI scans every 6 to 12 months may be appropriate for elderly patients, patients with small tumors, patients with significant medical conditions, and patients who refuse treatment.
Surgery
Surgery is the mainstay of treatment for acoustic neuroma. Patients with age under 65 years, medium to large-grade tumors, significant hearing loss, or higher headache severity scores will have more satisfying outcomes from surgery in comparison with observation. There are three main surgical approaches for the removal of an acoustic neuroma: translabyrinthine, retrosigmoid or sub-occipital, and middle fossa. Selection of a particular approach is based on several factors including the size and location of the tumor and whether or not preservation of hearing is a goal.
Primary Prevention
There are no established measures for the primary prevention of acoustic neuroma.
Secondary Prevention
Secondary prevention strategies following acoustic neuroma treatment include follow-up MRI scans.
References
- ↑ Carlson ML, Link MJ (2021). "Vestibular Schwannomas". N Engl J Med. 384 (14): 1335–1348. doi:10.1056/NEJMra2020394. PMID 33826821 Check
|pmid=value (help).